Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities:
Net loss	$ (5,684,038)	$ (5,243,207)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	54,041	52,662
Stock-based compensation expense	304,824	240,284
Change in deferred income taxes	(869,705)	(259,256)
Changes in operating assets and liabilities:
Prepaid expenses, deposits and other assets	(604,558)	(106,390)
Accounts payable, accrued expenses and other liabilities	151,411	48,320
Net cash used in operating activities	(6,648,025)	(5,267,587)
Cash flows provided by financing activities:
Proceeds from the sale of common stock	10,827,100	5,731,779
Proceeds from the exercise of common stock warrants	8,038,603
Payment of financing costs	(833,428)	(82,623)
Net cash provided by financing activities	18,032,275	5,649,156
Net increase in cash and cash equivalents	11,384,250	381,569
Cash and cash equivalents at beginning of period	14,177,349	7,991,172
Cash and cash equivalents at end of period	25,561,599	8,372,741
Supplemental disclosure of non-cash investing and financing activities:
Offering costs in accounts payable	148,900	80,206
Operating lease right of use asset and current and noncurrent liability		$ 334,205